Home/Filings/4/0001266375-07-000046
4//SEC Filing

PROGENICS PHARMACEUTICALS INC 4

Accession 0001266375-07-000046

CIK 0000835887operating

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 3:46 PM ET

Size

13.4 KB

Accession

0001266375-07-000046

Insider Transaction Report

Form 4
Period: 2007-06-21
Kremer Alton B
VP, Clinical Research
Transactions
  • Disposition to Issuer

    Common Stock

    2007-06-21$22.51/sh400$9,00416,990 total
  • Disposition to Issuer

    Common Stock

    2007-06-21$22.78/sh100$2,27816,165 total
  • Disposition to Issuer

    Common Stock

    2007-06-21$22.76/sh300$6,82816,490 total
  • Disposition to Issuer

    Common Stock

    2007-06-21$22.77/sh225$5,12316,265 total
  • Disposition to Issuer

    Common Stock

    2007-06-21$22.46/sh1,075$24,14517,390 total
  • Disposition to Issuer

    Common Stock

    2007-06-21$22.62/sh200$4,52416,790 total
Footnotes (1)
  • [F1]Sale under a 10b5-1 Plan, which was established in accordance with the policies and procedures of the Issuer.

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000835887

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 3:46 PM ET
Size
13.4 KB